| CD98 at the crossroads of adaptive immunity and cancer JM Cantor, MH Ginsberg Journal of Cell Science 125 (6), 1373-1382, 2012 | 226 | 2012 |
| CD98hc facilitates B cell proliferation and adaptive humoral immunity J Cantor, CD Browne, R Ruppert, CC Féral, R Fässler, RC Rickert, ... Nature immunology 10 (4), 412-419, 2009 | 120 | 2009 |
| CD98-Mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous Leukemia J Bajaj, T Konuma, NK Lytle, HY Kwon, JN Ablack, JM Cantor, D Rizzieri, ... Cancer Cell 30 (5), 792-805, 2016 | 109 | 2016 |
| Recruitment and activation of macrophages by pathogenic CD4 T cells in type 1 diabetes: evidence for involvement of CCR8 and CCL1 J Cantor, K Haskins The Journal of Immunology 179 (9), 5760-5767, 2007 | 106 | 2007 |
| Integrin‐associated proteins as potential therapeutic targets JM Cantor, MH Ginsberg, DM Rose Immunological reviews 223 (1), 236-251, 2008 | 89 | 2008 |
| Loss of T cell CD98 H chain specifically ablates T cell clonal expansion and protects from autoimmunity J Cantor, M Slepak, N Ege, JT Chang, MH Ginsberg The Journal of Immunology 187 (2), 851-860, 2011 | 81 | 2011 |
| Effector function of diabetogenic CD4 Th1 T cell clones: a central role for TNF-α J Cantor, K Haskins The Journal of Immunology 175 (11), 7738-7745, 2005 | 69 | 2005 |
| Antitumor activity of an anti‐CD98 antibody GM Hayes, L Chinn, JM Cantor, B Cairns, Z Levashova, H Tran, T Velilla, ... International Journal of Cancer, 2015 | 59 | 2015 |
| Interaction of kindlin-2 with integrin β3 promotes outside-in signaling responses by the αVβ3 vitronectin receptor. Z Liao, H Kato, M Pandey, JM Cantor, AJ Ablooglu, MH Ginsberg, ... Blood, 2015 | 39 | 2015 |
| Ubiquitylation of CD98 limits cell proliferation and clonal expansion JNG Ablack, PJ Metz, JT Chang, JM Cantor, MH Ginsberg J Cell Sci 128 (23), 4273-4278, 2015 | 31 | 2015 |
| Enhanced Integrin α4β1–Mediated Adhesion Contributes to a Mobilization Defect of Endothelial Progenitor Cells in Diabetes WT Abplanalp, DJ Conklin, JM Cantor, MH Ginsberg, M Wysoczynski, ... Diabetes 65 (11), 3505-3515, 2016 | 23 | 2016 |
| Fine-tuning tumor immunity with integrin trans-regulation JM Cantor, DM Rose, M Slepak, MH Ginsberg Cancer immunology research 3 (6), 661-667, 2015 | 20 | 2015 |
| Cutting Edge: Loss of T Cell RIAM Precludes Conjugate Formation with APC and Prevents Immune-Mediated Diabetes F Lagarrigue, FB Gertler, MH Ginsberg, JM Cantor The Journal of Immunology 198 (9), 3410-3415, 2017 | 15 | 2017 |
| Endothelial Cells Require CD98 for Efficient Angiogenesis Z Liao, JM Cantor Arteriosclerosis, Thrombosis, and Vascular Biology, ATVBAHA. 116.308335, 2016 | 12 | 2016 |
| CD98 is a potential target for ablating B cell clonal expansion and autoantibody in multiple sclerosis JM Cantor Journal of neuroimmunology 274 (1), 230-233, 2014 | 5 | 2014 |
| Interactions of macrophages and T cells in autoimmune diabetes J Cantor, K Haskins Drug Discovery Today: Disease Mechanisms 3 (3), 381-385, 2006 | 4 | 2006 |
| Homing Improvement: Boosting T Cell Trafficking for Cancer Immunotherapy JM Cantor Defects in T Cell Trafficking and Resistance to Cancer Immunotherapy, 127-161, 2016 | 2 | 2016 |
| Integrin activation controls regulatory T cell identity and stability JE Klann, SH Kim, KA Remedios, PJ Metz, AK Snider, J Lopez, JM Cantor, ... The Journal of Immunology 196 (1 Supplement), 125.3-125.3, 2016 | | 2016 |
| Effector function of pathogenic CD4 Th1 T cells in autoimmune diabetes JM Cantor UNIVERSITY OF COLORADO HEALTH SCIENCES CENTER, 2006 | | 2006 |
| A central role for TNF-alpha in the cytokine response of diabetogenic CD4+ T cell clones JM Cantor, K Haskins FASEB JOURNAL 19 (4), A938-A938, 2005 | | 2005 |
